Related Experiment Video
Updated: Nov 10, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies
Jaquelin Leyva-Hernández1, Ulises Rodríguez-Ortiz2, Asiel Arce-Sillas3
1Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Insurgentes Sur 3877, La Fama, México City, 14269, México; Unit for the Study of Neuroinflamation in Neurological Diseases, Instituto de Investigaciones Biomédicas, UNAM, and Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", México City 14269, México.
Abstract:
Rare conditions showing psychiatric symptoms and movement disorders have been linked with the presence of anti-glutamate decarboxylase antibodies. Proinflammatory and antiinflammatory immune responses were assessed in patients with neurological disorders associated to anti-glutamic acid decarboxylase antibodies (NDGAD). Immunoregulatory and proinflammatory cell populations were quantified by flow cytometry. No polarization toward Th1, Th2, or Th17 phenotypes was observed in NDGAD patients. Immunoregulatory responses were significantly reduced for Breg, activated Treg, Tr1, and Th3 cells, suggesting a deficient regulatory response, while intermediate monocyte levels were increased. The reduced levels of regulatory T and B cells suggest an impairment in regulatory immune response, while intermediate monocytes could be playing a role in the increased proinflammatory response.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

